Evidence map›Paper›PMID 40316789›Full record

ArticleCalcified tissue international2025

Developing a Standardised Dataset for Natural History Studies in Fibrous Dysplasia/McCune-Albright Syndrome.

Ana Luisa Priego Zurita, Oana O Bulaicon, Jillian Bryce, Nerea Arrieta, Magdalena Caballero Campos, Mariya Cherenko, Gaby Doxiadis, Corinna Grasemann, M Kassim Javaid, Helen McDevitt and 10 more

Abstract read
In one paragraph

Article in Calcified tissue international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ana Luisa Priego ZuritaDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Post box 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-4209-9996
Oana O BulaiconDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Post box 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0009-0004-8171-7253
Jillian BryceUniversity of Glasgow, Office for Rare Conditions, Glasgow, United Kingdom.ORCID http://orcid.org/0000-0002-4316-9477
Nerea ArrietaAsociación de Displasia Fibrosa, Bergara, Spain.
Magdalena Caballero CamposAsociación de Displasia Fibrosa, Bergara, Spain.ORCID http://orcid.org/0000-0002-3278-9531
Mariya CherenkoDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Post box 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-1731-2994
Gaby DoxiadisPatiëntenvereniging Fibreuze Dysplasie, Nijkerk, The Netherlands.
Corinna GrasemannDepartment of Paediatrics-Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum, Germany.ORCID http://orcid.org/0000-0003-1793-4603
M Kassim JavaidNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom.
Helen McDevittPaediatric Bone and Endocrinology, Royal Hospital for Children Glasgow, Glasgow, United Kingdom.
Stijn W van der MeerenDepartment of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-4777-560X
Diana Ovejero CrespoCentro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), IMIM (Hospital del Mar Research Institute), Barcelona, Spain.ORCID http://orcid.org/0000-0003-1312-4750
Luisa de SanctisPediatric Endocrinology, Regina Margherita Children Hospital-Aou Città Della Salute E Della Scienza, Torino, Italy.ORCID http://orcid.org/0000-0003-2113-6196
Lothar SeefriedOrthopaedic Department, University of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0003-1154-3388
Annemarie A Verrijn StuartDepartment of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-3999-8854
Daniele TessarisPediatric Endocrinology, Regina Margherita Children Hospital-Aou Città Della Salute E Della Scienza, Torino, Italy.ORCID http://orcid.org/0000-0002-6484-4371
Pieter Bas de WitteDepartment of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-9550-1630
Roland ChapurlatINSERM UMR 1033, Université Claude Bernard-Lyon 1, Service de Rhumatologie, Chu Edouard-Herriot, Lyon, France.ORCID http://orcid.org/0000-0001-8214-6385
S Faisal AhmedDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Post box 9600, 2300 RC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-0689-5549
Natasha M Appelman-DijkstraDepartment of Internal Medicine, Division of Endocrinology, Leiden University Medical Center, Albinusdreef 2, Post box 9600, 2300 RC, Leiden, The Netherlands. N.M.Appelman-Dijkstra@lumc.nl.ORCID http://orcid.org/0000-0001-5035-127X

Funding

Consumers, Health, Agriculture and Food Executive Agency 777215Consumers, Health, Agriculture and Food Executive Agency 946831
6 · The paper itself

Abstract

Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare and complex condition caused by somatic variants in the GNAS gene that lead to a wide clinical spectrum. The diagnostic process and therapeutic pathway vary per centre and therefore international harmonisation of data collection should be pursued. To understand the diagnostic pathways and clinical outcomes of patients with FD/MAS reported on an electronic-reporting tool (e-REC) across European centres to guide the develop a condition-specific module within the European Registries for Rare Endocrine and Bone conditions. Centres that reported new cases on e-REC between October 2019 and May 2021 were approached to complete a survey in May 2021. Fifty-eight cases were included. Median age at presentation was 20 years (range, 0, 72). Of the 58 included cases, the presentation type was isolated craniofacial FD in 19 (33%), monostotic FD in 15 (26%), polyostotic FD in 10 (17%), and MAS in 13 (13%). Standardised questionnaires to assess pain and quality of life were used routinely in 21/58 patients (36%). The majority of patients had more than one healthcare provider, with great diversity in the specialty of the coordinating physician. A standardised dataset module for FD/MAS was developed through collaboration with the FD/MAS study group, incorporating expert consensus and clinical insights. Key variables were identified to capture essential diagnostic, clinical, and patient-reported outcomes. The diagnostic path for patients with FD/MAS across European expert centres is variable. The outcomes of this study allowed the building of the first international FD/MAS-specific data collection.

Indexed as

Fibrous Dysplasia, PolyostoticAdolescentAdultAgedChildChild, PreschoolEuropeFemaleHumansInfantInfant, NewbornMaleMiddle AgedQuality of LifeRegistriesSurveys and QuestionnairesData collectionFibrous dysplasiaMcCune-Albright syndromeRare bone diseaseRegistries

Identifiers

PMID40316789
PMCPMC12048454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.